CD34 AND FACTOR-XIIIA IN THE DIFFERENTIAL-DIAGNOSIS OF DERMATOFIBROMA AND DERMATOFIBROSARCOMA PROTUBERANS
CD34 AND FACTOR-XIIIA IN THE DIFFERENTIAL-DIAGNOSIS OF DERMATOFIBROMA AND DERMATOFIBROSARCOMA PROTUBERANS
复制标题
DOI:
10.1097/00000372-199310000-00003
复制
发表时间:
1993-10-01
影响因子:
1.1
通讯作者:
LILLEMOE, T
中科院分区:
文献类型:
--
作者:
ABENOZA, P;LILLEMOE, T
To assess the use of anti-CD34 and anti-factor-XIIIa antibodies for the differential diagnosis of dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP), we stained 40 DFs and 13 DFSPs. A significant population of dendritic and spindle cells was reactive with anti-factor-XIIIa in 90% of DFs. In DFSP, most cases had very few or no reactive cells for this antiserum and reactivity was confined to the infiltrating edges of the neoplasm or to a very low percentage of cells within the bulk of the tumor. A significant overlap was detected, a reason why the stain is useful but lacks absolute specificity for this purpose. Human progenitor cell antigen (CD34) was found in all cases of DFSP that had 50-100% of reactive cells, but in only five DFs. In DFs, the reactivity for CD34 was focal, with only less-than-or-equal-to 20% positive cells. When used together with other histopathological criteria, factor-XIIIa antibody and particularly CD34 may help to differentiate these two processes.